09February

Novo Nordisk files annual report with the SEC ... Read more

07February

Novo Nordisk publishes its 2016 Annual Report ... Read more

14February

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

13February

Novo Nordisk A/S - Share repurchase programme ... Read more

07February

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

06February

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

Contact Media

If you have any queries please feel free to contact Media Relations at Novo Nordisk headquarters or one of our global offices.

Contact Media Relations

 

Novo Nordisk News


device manufaturing, Hillerød Denmark

Novo Nordisk increased adjusted operating profit by 6% in local currencies in 2016

2 February - Lars Fruergaard Jørgensen, president and CEO: “2016 was a challenging year. While we met our financial guidance for the year, strong market headwinds in the USA meant that we had to revise our long-term financial targets. However, 2016 was also a year, in which we announced very encouraging clinical data for our key products, providing a solid foundation for future growth.”

Read the announcement and all the details regarding the full year 2016

 


The Novo Nordisk Research Centre Oxford

Novo Nordisk and University of Oxford entering collaboration on type 2 diabetes with GBP 115m investment

30 January - University of Oxford and Novo Nordisk has announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. Sir John Bell, Regius Professor of Medicine, University of Oxford, said: “We see the collaboration with Novo Nordisk as an outstanding opportunity to mix competence embedded at our campus with Novo Nordisk’s groundbreaking research and results in diabetes. This collaboration underlines the importance of shared research and cutting-edge science across boundaries". The Novo Nordisk Research Centre Oxford will employ up to 100 Novo Nordisk researchers.

Read the press release

 


Novo Nordisk and Glooko partner to develop digital health solutions 

Novo Nordisk and Glooko will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The companies aim to deliver personalised, digital services to support people with diabetes in areas including treatment adherence and blood glucose management. Read all the details



Cities changing diabetes in Shanghai

Wake-up call for urban health!

12 October - Monday 17 October, governments and international bodies met for Habitat III in Quito, Ecuador – a historic summit that would define the big priorities for urbanisation in the ‘New Urban Agenda’. In an open letter in the New York Times, the mayors, city and health leaders of six major cities expressed their concern about the urban crisis the world is just starting to wake up to.  

Read the open letter

 


Sarah Ahmed from Ethopia has type 1 diabetes

Novo Nordisk committed to guarantee access to insulin

22 September - Access to reliable and affordable supplies of insulin is a challenge for many in the poorest nations in the world. Lars Rebien Sørensen has pledged to extend the current programme from 2001 and expand Novo Nordisk's commitment to supply human insulin at fixed low prices to the Least Developed Countries and low-income nations; the programme will now be extended to cover selected organisations providing relief in humanitarian situations.

Read all the details about Novo Nordisk's programme on access to insulin

The diabetes challenge - get an overview of Novo Nordisk's commitment 


World Diabetes Day in a War Zone

What do you do on World Diabetes Day when you have an inhuman situation in a war zone? Novo Nordisk employees in Libya give you insights from the field.

Read the whole story

WDD in a war zone

The digital health connection in Africa

A commitment to children with type 1 diabetes and the growing uptake and use of mobile technology in Africa were the catalysts for action on the ground – and in cyberspace.

Read the story

Digital health in Africa

The one rule we have to break!

Watch the film featuring the 'Rule of Halves' illustrating the challenges that need to be overcome to get diabetes under control. Or see some of the Leading Lights movies with six urbanisation experts giving their perspectives on #urbandiabetes.

 

This film features the 'Rule of Halves' illustrating the challenges that need to be overcome to get diabetes under control
This film features the 'Rule of Halves' illustrating the challenges that need to be overcome to get diabetes under control
This film features the 'Rule of Halves' illustrating the challenges that need to be overcome to get diabetes under control

Calendar

Annual Report 2016
24FebruaryDenmark

Our carbon footprint

How can Novo Nordisk play a role in offering solutions that are good for people’s health and the planet? Read what CEO Lars Fruergaard Jørgensen says and how we can take carbon emissions to the product level.


An exceptional patient entrepreneur!

Winner of Lyfebulb award

Dec '16 - Patient entrepreneur Brianna Wolin was selected as winner of the Lyfebulb-Novo Nordisk Innovation Award: 'Find Your Ditto' - a mobile platform which connects patients living with the same chronic illness for on-demand, in-person peer support.

Read more about the Lyfebulb-Novo Nordisk partnership


LEADER clinical trial backgrounder

What are cardiovascular outcomes trials? What's LEADER? See and read about all the details.


Growth challenges


A national strategy for Danish life science is needed; read about the potential of the future - an even smarter Denmark, world-class knowhow, more Danish entrepreneurship - an even more attractive Denmark. Read the analysis in Danish or English.


Novo Nordisk in brief


Get an instant impression of what Novo Nordisk is about, see the numbers and read about partnership activities that drive change. 

Download Novo Nordisk backgrounder 


Novo Nordisk Stories

Views on obesity

The view on obesity is slowly changing, but there are still many myths about the disease that all contribute to creating barriers for proper treatment.

Read the story

Theme: Innovation